To evaluate the effect and safety of treatment with low-calorie formula diet on renal function and proteinuria in obese patients with diabetic nephropathy. DESIGN: Prospective study on safety and efficacy of a 4-week low-calorie (11-19 kcal/kg/day) normal-protein (0.9-1.2 g/kg/ day) diet partly supplemented with formula diet. SUBJECTS: In all, 22 obese patients with diabetic nephropathy (BMI: 30.475.3 kg/m 2 , HbA1c: 7.171.4%, serum creatinine: 172.4757.5 mmol/l, urinary protein: 3.372.6 g/day). RESULTS: The mean body weight decreased by 6.273.0 kg. The mean systolic blood pressure, creatinine, blood urea nitrogen, urinary protein, and 8-hydroxydeoxyguanosine decreased significantly by 7.5712.7 mmHg, 41.6723.9 mmol/l, 1.5071.61 mmol/l, 1.871.7 g/day, and 3.173.6 ng/mg creatinine, respectively. No patient had increased serum creatinine and urinary protein. Mean creatinine clearance (40.6717.9 to 46.1714.6 ml/s/1.73 m 2 ) and serum albumin showed no significant changes. Dserum creatinine and Durinary protein correlated with Dbody weight (r ¼ 0.62 and 0.49, respectively) and Dvisceral fat area (r ¼ 0.58 and 0.58, respectively), but did not correlate with Dsystolic blood pressure, Dfasting blood glucose and Dsubcutaneous fat area. CONCLUSION: These results suggested that weight reduction using formula diet might improve renal function and proteinuria safely for a short term in obese patients with diabetic nephropathy.
Introduction
Diabetic nephropathy is considered to be one of the most common causes of renal failure in Japan. Once overt proteinuria has set in, there are no therapeutic interventions that can halt the progressive loss of renal function. The decline to end-stage renal disease is often rapid with a mean rate of decline of glomerular filtration rate (GFR) of approximately 1 ml/min/month. 1 Although there is no therapy for progressive loss of renal function, it can be delayed by antihypertensive therapy 2 and may be influenced by the quality of metabolic control. 3 Recent report has indicated a strong association of oxidative stress with diabetic nephropathy. 4 In dietary treatment of diabetic nephropathy, several studies reported that high-calorie, low-protein diet was beneficial for renal function and proteinuria. [5] [6] [7] On the other hand, obesity is recognized as a risk factor of renal dysfunction. The mechanism by which obesity deteriorates the renal function is not fully understood. Weight loss has been shown to induce a dramatic decrease in proteinuria in patients with obesity-related proteinuria, 8 but no study has investigated the effect of weight loss in obese patients with diabetic nephropathy. Formula diet, which is normal-protein diet, is used for the treatment of obesity. Currently, normal-protein diet is not recommended for diabetic nephropathy. However, Nakamura et al 9 reported
that the GFR responded differently to various proteins, and that some proteins do not have adverse effects on GFR. Their report indicated that formula diet, which mainly consists of soybean and dairy product, might be safe for diabetic nephropathy. We therefore designed a prospective study to evaluate the effect and safety of low-calorie formula diet on renal function and proteinuria in obese patients with diabetic nephropathy. Furthermore, we studied whether weight loss might affect the oxidative stress in diabetic nephropathy.
Methods

Patients
In all, 22 obese patients (16 males and six females) with diabetic nephropathy were studied and observed under hospitalization. We selected patients who satisfied the following criteria: obesity (body mass index (BMI) 425 kg/ m 2 ), presence of diabetic retinopathy, proteinuria (urinary albumin 4300 mg/day) and serum creatinine level less than 265.2 mmol/l. Excluded were patients with unstable diabetic retinopathy and presence of pleural effusion and severe leg edema. Baseline characteristics of these study patients are shown in Table 1 . Before the study, the patients were prescribed a daily caloric intake of 25-30 kcal/kg and 0.8 g/ kg protein at least for 3 months. Drugs such as statins, probucol, angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, b-blockers and diuretics that had been taken for more than 2 months prior to the study were continued during this study, on condition that the doses remained unchanged. Drugs for diabetes mellitus such as insulin and sulfonyl ureas were reduced or discontinued at the time of hypoglycemia.
Diets
The patients were prescribed a total daily caloric intake of 740 or 970 kcal (11-19 kcal/kg) A formula diet consisting of liquid protein (ObeCure; US Cure Inc.,. Tokyo, Japan) providing 170 kcal/pack was used as part of the diet. Every day for 4 weeks, the patients either consumed one meal of formula diet meal containing 170 kcal and two ordinary meals of 400 kcal each (total; 970 kcal), or two meals of formula diet and one ordinary meal (total; 740 kcal). Salt intake was 2.79 g/day for the 740 kcal diet and 4.90 g/day for the 970 kcal/day diet.
Clinical and laboratory measurements
Body weight measurement and blood collection for laboratory evaluations were performed after an overnight fast. Blood pressures were measured in the afternoon after 5 min of rest in a sitting position. Twenty-four-hour urine sample was collected for urinary protein and creatinine clearance measurements. Creatinine clearance was calculated by measuring intrinsic creatinine in serum and urine. Area of visceral fat was evaluated using CT. The CT scan was performed at the umbilical level with the subject resting in the supine position. The visceral fat area was traced manually along the inside of the abdominal wall, and the number of pixels showing CT values between À50 and À150 Hounsfield units was calculated for this region. The subcutaneous fat area was calculated as follows: total fat areavisceral fat area. Urinary 8-hydroxydeoxyguanosine (8-OHdG) is considered a biological marker of in vivo oxidative DNA damage. 10 We utilized the 8-OHdG as an oxidative stress marker in this study. Body weight, systolic blood pressure, diastolic blood pressure, blood urea nitrogen (BUN), serum creatinine, serum albumin, fasting blood glucose, HbA 1 c, total cholesterol (TC), triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C), urinary protein and creatinine clearance were measured once a week (week 0-4). Visceral fat, subcutaneous fat and 8-OHdG were measured before and after the study.
Informed consent
We explained to the patients that the study would be discontinued under the following circumstances: aggravation of serum creatinine and proteinuria, progression of diabetic retinopathy, and problem relevant to weight loss using formula diet in the study. With full informed consent, the investigation was permitted by all patients.
Statistical analysis
The results are expressed as mean7s.d. A t-test was used for group comparisons. P-values of o0.05 were considered significant.
Results
During the 4 weeks, no patient showed progression of diabetic retinopathy in this study. Mean body weight decreased significantly (Po0.0001) from 85.2717.0 to 79.0717.2 kg (Table 1) . Mean systolic blood pressure, diastolic blood pressure, HbA1c, TC and TG showed (Figure 1a ) and decrease in visceral fat (r ¼ 0.58, Po0.05) (Figure 2a) . The Dserum creatinine showed no significant correlation with Dsystolic blood pressure, diastolic blood pressure, fasting blood glucose, HbA1c, TC, TG, HDL-C (data not shown) and subcutaneous fat (Figure 2b ). Decrease in urinary protein also correlated significantly with weight loss (r ¼ 0.49, Po0.05) Figure 1 Formula diet for diabetic nephropathy A Saiki et al ( Figure 1b ) and decrease in visceral fat (r ¼ 0.58, Po0.05) (Figure 2c ). The Durinary protein showed no significant correlation with Dsystolic blood pressure, diastolic blood pressure, fasting blood glucose, HbA1c, TC, TG, HDL-C (data not shown) and subcutaneous fat (Figure 2d) .
During the 4 weeks in this study, mean 8-OHdG (considered an oxidative stress marker) decreased significantly (Table 1) . However, the mean 8-OHdG showed no significant correlation with weight loss (r ¼ 0.15, P ¼ 0.66), decrease in serum creatinine (r ¼ 0.02, P ¼ 0.94), or decrease in urinary protein (r ¼ 0.23, P ¼ 0.50).
The changes of serum creatinine per weight loss and the changes of urinary protein per weight loss were stratified by 4 grades of weight loss. No between-group differences were detected for the change of serum creatinine (Figure 3a) and for the change of urinary protein (Figure 3b ).
Discussion
Usually, high-calorie low-protein diet is considered to protect renal function and prevent aggravation of proteinuria in diabetic nephropathy. [5] [6] [7] Correction of the abnormal glomerular hemodynamics has been reported to be the mechanism by which low protein diet improves renal damage in diabetic nephropathy. 11 However, the effect of weight loss on renal function in obese patients with diabetic nephropathy is not fully understood. In this study, we observed obese patients with diabetic nephropathy treated with a low-calorie normal-protein diet for 4 weeks under hospitalization. As a result, the mean serum creatinine decreased significantly by 41.6728.9 mmol/l, and the mean urinary protein also decreased significantly by 1.871.7 g/ day. Although the serum creatinine might be affected by reduction of skeletal muscle, the mean creatinine clearance increased showed an apparent increase in this study (not significant). These results suggest that a low-calorie diet taken by obese subjects with diabetic nephropathy may improve renal function and proteinuria in the short term. In this study, both serum creatinine and the urinary protein correlated significantly with weight loss. These results indicate that weight loss may be the most important factor for improving renal function and proteinuria in diabetic nephropathy with obesity. However, several confounding factors should be examined. First, glycemic control and blood pressure have been reported to impact renal function and proteinuria. The United Kingdom Prospective Diabetes Study (UKPDS) 12 reported that tight blood pressure control in type 2 diabetes suppressed proteinuria and progression to end-stage renal failure. Moreover, the Diabetes Control and Complications Trial (DCCT) 13 on type 1 diabetes and the Kumamoto study 14 on type 2 diabetes have reported that intensive glycemic control suppresses the progression of nephropathy. In the present study in which medications remained unchanged and only the diet was modified, the mean blood pressure decreased significantly while blood glucose was apparently lowered but not significantly. However, changes in serum creatinine and urinary protein did not correlate with changes in blood pressures and blood glucose, whereas they correlated with weight loss. Therefore, we speculate that the blood pressure effect may have partially contributed to improving renal function and proteinuria, but weight loss has the major effect. Another factor is salt intake. In the present study, dietary salt intake was low (2.70 or 4.90 g/day). Cianciaruso et al 15 observed improvements in renal function and proteinuria with low sodium intake compared to high sodium intake in patients with progressive renal disease. Allen et al 16 reported suppression of hyperfiltration, renal enlargement and albuminuria by salt restriction in diabetic rats. In the present study, we did not measure urinary electrolytes and the effect of salt restriction on renal function and urinary protein is unknown. However, the significant correlation between weight loss and serum creatinine and urinary protein excretion indicates that weight loss, at least, contributes greatly to the improvement. Several studies showed that obese patients could develop proteinuria and progressive loss of renal function, 17, 18 and weight loss improved them. 8, 19 The proposed mechanisms by which obesity increased renal risk include increasing GFR, 20 focal segmental glomerulosclerosis, 21 activation of the rennin-angiotensin system, 8 and adipocyte-derived cytokines. 22 However, the impact mechanism underlying the increased renal risk of obesity is not fully understood. In this study, both serum creatinine and urinary protein correlated significantly with visceral fat area. These results suggested that the adipocyte-derived cytokines might affect nephropathy directly or indirectly. Wolf et al 22 reported that leptin stimulated renal glomerular endothelial cell proliferation. A recent study showed that human adipose angiotensinogen gene expression was associated with abdominal fat distribution in obesity, 23 and that might have an effect on nephropathy. Moreover, the progression of diabetic nephro- Formula diet for diabetic nephropathy A Saiki et al pathy has been suggested to involve oxidative stress. 4 On the other hand, obesity has been shown to increase oxidative stress. 24, 25 In this study, 8-OHdG, a recognized oxidative stress marker, decreased significantly after 4 weeks. Although the decreases in body weight, serum creatinine and urinary protein did not correlate with the decrease in 8-OHdG, our results suggested that the decrease in oxidative stress might be one of the mechanisms by which weight loss improved renal function and proteinuria in obese subjects with diabetic nephropathy. The safety of weight loss in obese subjects with diabetic nephropathy was studied. Although rapid glycemic control might accelerate the progression of diabetic retinopathy, 26 no patient showed progression of the retinopathy in this study. Serum albumin did not change significantly despite using the formula diet. It is important to note that all patients showed decreases of serum creatinine and urinary protein. To find out the optimal weight loss to improve renal function, the changes of serum creatinine and urinary protein per weight loss were stratified by grades of weight loss. The rates of improving renal function and proteinuria were not different among the grades of weight loss. These findings imply that for a short observation period of 4 weeks, serum creatinine and urinary protein are improved as long as there is weight loss, irrespective of the amount of loss. In other words, short-term use of formula diet to achieve weight loss appears to be a safe method to improve renal function and proteinuria in obese patient with diabetic nephropathy because the effect is achieved as long as the patient loses weight with no risk of excessive weight loss.
In this study, we utilized a formula diet providing 62-64 g of protein (0.9-1.2 g/kg) a day as a normal protein diet for prevention of protein catabolism. Usually, low-protein diet is recommended for diabetic nephropathy. Nakamura et al 9 reported that alanine, glycine and arginine loads induced glomerular hyperfiltration in vivo. The amino-acid composition of ObeCure, a normal-protein diet, might not adversely affect diabetic nephropathy. In the future, we should compare a low-protein diet for obese subjects with diabetic nephropathy. In this study, weight loss might have improved nephropathy related to obesity, but whether weight loss improves diabetic nephropathy is not fully understood. We should conduct long-term study on the effect of weight loss on diabetic nephropathy in obese subjects.
Conclusion
Weight loss using formula diet improved the renal function and proteinuria in obese patients with diabetic nephropathy in a short-term study. The mean serum creatinine and mean urinary protein decreased significantly, and both serum creatinine and urinary protein correlated significantly with weight loss. These results suggest that weight loss in obese patients with diabetic nephropathy achieved by taking a formula diet might improve renal function and proteinuria safely in the short term, and the changes of adipocytederived cytokines and oxidative stress might be the mechanisms by which weight loss improved renal function and proteinuria in diabetic nephropathy with obesity.
